MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Adult hippocampal neurogenesis-associated memory performance in people with Parkinson’s disease with and without cognitive impairment

L. Batzu, A. Podlewska, J. Staunton, P. Tall, V. Leta, C. Kim, S. Thuret, K. Ray Chaudhuri (London, United Kingdom)

Meeting: 2023 International Congress

Abstract Number: 343

Keywords: Cognitive dysfunction, Neurogenesis, Parkinson’s

Category: Parkinson's Disease: Cognitive functions

Objective: To evaluate the role of adult hippocampal neurogenesis (AHN)-associated memory measures to the cognitive performance of people with Parkinson’s disease (PwP) with or without cognitive impairment as a potential biomarkers.

Background: Episodic memory impairment is common in Parkinson’s disease (PD) and is associated with an increased risk of dementia1,2. Dysfunction in AHN, the generation of new neurons in the subventricular zone of the dentate gyrus in the hippocampus, has been associated with episodic memory deficit, particularly in pattern separation and recognition memory3, and can be assessed with the Mnemonic Similarity Task (MST)4.

Method: Clinical and demographic data were collected from a cohort of PwP recruited at the Parkinson’s Foundation Centre of Excellence at King’s College Hospital, London, UK. Global cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA) and a cut-off of <26 was used to define the presence of cognitive impairment. Subjective memory decline (SMD) was assessed by the score of the first memory item of the MDS-NMS scale5.  In the testing phase of the MST task, participants decided whether visualised images were “old”, “similar” or “new”, compared to images previously shown during an encoding phase. A verbal measure of episodic memory, the Hopkins Verbal Learning Test-Revised (HVLT-R), was also assessed.

Results: Among 18 PwP, six were defined as cognitively impaired (CI) and 12 as cognitively unimpaired (CU). Significant differences between the two groups were observed in the Delayed Recall and Retention scores of HVLT-R (p<0.001), while no significant differences in MST outcomes were detected (Table). However, in the CI group, a significant positive correlation was found between the recognition score of the MST and the HVLT-R recognition discrimination index (rho=0.845, p=0.034), while a significant negative correlation was observed in the CU group between the lure discrimination index of the MST and the SMD score (rho=-0.606, p=0.037).

Conclusion: In this exploratory study, we observed an association between visual and verbal recognition memory in PwP with cognitive impairment. On the other hand, pattern recognition memory correlated with a measure of SMD in CU subjects. These preliminary findings suggest that AHN-associated memory outcomes may signpost different stages of memory dysfunction in PwP.

Table 1

References: [1] Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021 Jul 1;7(1):47. doi: 10.1038/s41572-021-00280-3. Erratum in: Nat Rev Dis Primers. 2021 Jul 13;7(1):53. PMID: 34210995.
[2] Das T, Hwang JJ, Poston KL. Episodic recognition memory and the hippocampus in Parkinson’s disease: A review. Cortex. 2019 Apr;113:191-209. doi: 10.1016/j.cortex.2018.11.021. Epub 2018 Dec 4. PMID: 30660957; PMCID: PMC6445686.
[3] Kim C, Pinto AM, Bordoli C, Buckner LP, Kaplan PC, Del Arenal IM, Jeffcock EJ, Hall WL, Thuret S. Energy Restriction Enhances Adult Hippocampal Neurogenesis-Associated Memory after Four Weeks in an Adult Human Population with Central Obesity; a Randomized Controlled Trial. Nutrients. 2020 Feb 28;12(3):638. doi: 10.3390/nu12030638. PMID: 32121111; PMCID: PMC7146388.
[4] Stark SM, Yassa MA, Lacy JW, Stark CE. A task to assess behavioral pattern separation (BPS) in humans: Data from healthy aging and mild cognitive impairment. Neuropsychologia. 2013 Oct;51(12):2442-9. doi: 10.1016/j.neuropsychologia.2012.12.014. Epub 2013 Jan 9. PMID: 23313292; PMCID: PMC3675184.
[5] Chaudhuri KR, Schrag A, Weintraub D, Rizos A, Rodriguez-Blazquez C, Mamikonyan E, Martinez-Martin P. The movement disorder society nonmotor rating scale: Initial validation study. Mov Disord. 2020 Jan;35(1):116-133. doi: 10.1002/mds.27862. Epub 2019 Sep 30. Erratum in: Mov Disord. 2020 Oct;35(10):1892. PMID: 31571279; PMCID: PMC7037759.

To cite this abstract in AMA style:

L. Batzu, A. Podlewska, J. Staunton, P. Tall, V. Leta, C. Kim, S. Thuret, K. Ray Chaudhuri. Adult hippocampal neurogenesis-associated memory performance in people with Parkinson’s disease with and without cognitive impairment [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/adult-hippocampal-neurogenesis-associated-memory-performance-in-people-with-parkinsons-disease-with-and-without-cognitive-impairment/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/adult-hippocampal-neurogenesis-associated-memory-performance-in-people-with-parkinsons-disease-with-and-without-cognitive-impairment/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley